Promoting life course vaccination

Rejuvenation Research

Volumn 14, Issue 1, 2011, Pages 75-81

  Michel, Jean Pierre ^a   Lang, Pierre Olivier ^a  

^a University of GenevaMedical School and University Hospitals   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; PNEUMOCOCCUS VACCINE; STAPHYLOCOCCUS VACCINE; VACCINE;

DIPHTHERIA; HERD IMMUNITY; HUMAN; INFECTION; INVASIVE PNEUMOCOCCAL DISEASE; MEASLES; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL INFLUENZA; STAPHYLOCOCCUS INFECTION; TETANUS; VACCINATION;

AGED; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; GERIATRICS; HUMANS; VACCINATION; VACCINES;

EID: 79951832329     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2010.1078     Document Type: Review

References (51)

1. Suhrcke M, McKee M, Stuckler D, Suk JE, Tsolova S, Se-menza JC. The economic crisis and infectious disease control. Euro Surveill 2009;14.
2. Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H. Coalition of advocates to vaccinate of Western European citizens aged 60 years and older. Aging Clin Exp Res 2009;21:254-257.
3. Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res 2009;12:127-135.
4. Gusmano MK. Life course vaccination and health ageing. Aging 2009;21:258-263.
5. Michel JP, Newton JL, Kirkwood TB. Medical challenges of improving the quality of a longer life. JAMA 2008;299:688-690. (Pubitemid 351252729)
6. Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 2009;27:3240-3244.
7. WHO. Influenza vaccines: WHO position paper. Wkly Epidemiol Rec 2005;80:277-288.
8. European Parliament. [P6 - TA (2005) 0406] 26 October, European Community, Brussels, 2005.
9. WHO. Resolution 56.19; 23 May. In; 2003: World Health Organization, Geneva, 2003.
10. Flower D. Bioinformatics for Vaccinology, 2nd ed. Wiley-Blackwell, Oxford, 2008.
11. WHO. WHO- Vaccine Preventable Diseases: Monitoring System - Global Summary. World Health Organisation, Geneva, 2007.
12. WHO. The centralized information system for infectious diseases (CISID). WHO, Geneva, 2009.
13. De Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008;27:218-223.
14. Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Pediatr Infect Dis J 2007;26:806-810. (Pubitemid 47329851)
15. Hu JJ, Lu CY, Chang LY, et al. Survey of pertussis in patients with prolonged cough. J Microbiol Immunol Infect 2006;39:54-58.
16. Huang Y, Rohani P. Age-structured effects and disease interference in childhood infections. Proc Biol Sci 2006;273: 1229-1237. (Pubitemid 47324458)
17. Cortese MM, Baughman AL, Brown K, Srivastava P. A "new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med 2007;32:177-185.
18. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:S58-S61. (Pubitemid 40676539)
19. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007;25:2634-2642. (Pubitemid 46400927)
20. Riffelmann M, Littmann M, Hulsse C, Hellenbrand W, Wirsing Von Konig CH. Pertussis: Not only a disease of childhood. Dtsch Arztebl Int 2008;105:623-628.
21. UN. World population prospects: the 2008 revision population database. United Nations, 2009. Accessed at http:// esa.un.org/unpp/.
22. Baeyens JP, Lang PO, Michel JP. Willingness to vaccinate and to be vaccinated in adults. Aging Clin Exp Res 2009; 21:244-249.
23. McElhaney JE, Effros RB. Immunosenescence: What does it mean to health outcomes in older adults? Curr Opin Immunol 2009;21:418-424.
24. Szucs TD, Muller D. Influenza vaccination coverage rates in five European countries- a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005;23:5055-5063. (Pubitemid 41318153)
25. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montano LF, Nichol KL, Puig-Barbera J, Schmitt J, Stephenson I. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009;27:5043-5053.
26. White-Williams C, Brown R, Kirklin J, St. Clair K, Keck S, O'Donnell J, Pitts D, Van Bakel A. et al. Improving clinical practice: should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant 2006;25: 320-323. (Pubitemid 43290663)
27. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009;58:446-458.
28. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24:1159-1169. (Pubitemid 43202262)
29. Siscovick DS, Raghunathan TE, Lin D, Weinmann S, Arbo-gast P, Lemaitre RN, Psaty BM, Alexander R, Cob LA. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000;152:674-677.
30. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004;25:25-31. (Pubitemid 38055589)
31. Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J 2004;31:28-32. (Pubitemid 38366812)
32. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;29:1350-1358. (Pubitemid 351806477)
33. Szucs TD. Health economic research on vaccinations and immunisation practices- an introductory primer. Vaccine 2005;23:2095-2103. (Pubitemid 40341434)
34. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007;167: 1938-1943. (Pubitemid 47606632)
35. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-970.
36. McCullers JA. Planning for an influenza pandemic: Thinking beyond the virus. J Infect Dis 2008;198:945-947.
37. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM. Influenza vaccination as secondary prevention for cardiovascular disease. J Am Coll Cardiol 2006;48:1498-1502.
38. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344: 889-896. (Pubitemid 32224397)
39. Blank PR, Szucs TD. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines 2009;8:425-433.
40. Stuck AE, Kharicha K, Dapp U, Anders A, von Rentein-Kruse W, Meier-Baumgartner HP, Harari D, Swift CG, Iva-nova K, Egger M, Gillmann G, Higa JH, Beck JC, Iliffe S. Development, feasibility and performance of a health risk appraisal questionnaire for older persons. BMC Med Res Methodol 2007;7:1.
41. Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: A meta-analysis. Cmaj 2009;180:48-58.
42. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcellis V, Margolis A, Adair RK, Clemens JD. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-1460.
43. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW, for the Vaccine Safety Datalink. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-1755. (Pubitemid 36514705)
44. Dominguez A, Salleras L, Fedson DS, Izquierdo C, Ruiz L, Ciruela P, Fenoll A, Casal J. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: A case-control study. Clin Infect Dis 2005;40:1250-1257. (Pubitemid 40570233)
45. Deaths from chronic obstructive pulmonary disease- United States, 2000-2005. MMWR Morb Mortal Wkly Rep 2008;57:1229-1232.
46. Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, Mcintyre PB. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009;27:1628-1636.
47. Reingold AH, Farley, MM et al. Direct and Indirect Effects of Routine Vaccination of Children with 7-Valent Pneumo-coccal Conjugate Vaccine on Incidence of Invasive Pneu-mococcal Disease - United States, 1998-2003. Morb Mortal Wkly Rep 2005;54:893-897.
48. Vitek CR, Wharton M. Diphtheria in the former Soviet Union: Reemergence of a pandemic disease. Emerg Infect Dis 1998;4:539-550. (Pubitemid 28553679)
49. Richard J, Masserey-Spicher V, Santibanez S, Mankertz A. Measles outbreak in Switzerland-an update relevant for the European football championship (EURO 2008). Euro Surveill 2008;13.
50. Gusmano MK, Michel JP. Life course vaccination and healthy aging. Aging Clin Exp Res 2009;21:258-263.
51. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009;21:201-209.